Seven Springs Wealth Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Seven Springs Wealth Group's BMY Position: Q2 2021 in Review
Seven Springs Wealth Group sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 250 shares — an estimated $16K sold.
Seven Springs Wealth Group first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $30K in Q4 2019. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Seven Springs Wealth Group reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Seven Springs Wealth Group sold 250 Bristol-Myers Squibb shares in Q2 2021, an estimated $16K.
- Seven Springs Wealth Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
- Seven Springs Wealth Group's Bristol-Myers Squibb position peaked at $30K in Q4 2019.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Seven Springs Wealth Group's 13F filing for Q2 2021, filed 27 Jul 2021.